Blue Earth Therapeutics raised nearly $77M in a Series A financing round led by Soleus and Sands Capital to further develop PSMA-targeted therapies for prostate cancer.
Amount Raised
$77 Million
Round Type
Series A
OxfordBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
Blue Earth Therapeutics has raised nearly $77 million in new financing. This funding will support the advancement of their development of prostate-specific membrane antigen-targeted therapies.
Quick answer
Blue Earth Therapeutics raised $77 Million in a Series A round, dated October 31, 2024. Investors: Soleus and Sands Capital. Blue Earth Therapeutics is based in Oxford, England, United Kingdom.
- How much did Blue Earth Therapeutics raise?
- Blue Earth Therapeutics raised $77 Million in a Series A round on October 31, 2024.
- Who invested in Blue Earth Therapeutics?
- Soleus and Sands Capital are named as investors in this round.
- What does Blue Earth Therapeutics do?
- Blue Earth Therapeutics Ltd is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat patients who have cancer.
- Where is Blue Earth Therapeutics based and how big is it?
- Blue Earth Therapeutics is based in Oxford, England, United Kingdom. Fundz records about 12 employees.
- Who are the decision-makers at Blue Earth Therapeutics?
- Fundz holds 1 contact at Blue Earth Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Blue Earth Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- BioSapien raised $5.5M (Series A) on December 13, 2024.
- East Ocyon Bio raised $4.2M (Seed) on December 11, 2024.
- Orakl Oncology raised $12M (Seed) on December 3, 2024.
- TransCode Therapeutics raised $8M on December 2, 2024.
- Strata Oncology raised $6.1M on November 8, 2024.
- Qnovia raised $14M on October 29, 2024.
Who to call at Blue Earth Therapeutics, and when
A new round usually means Blue Earth Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Blue Earth Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Blue Earth Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Blue Earth Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Blue Earth Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBlue Earth Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.